Nuvation Bio Inc. - Common Stock (NUVB)

Q1 2024 13F Holders as of 3/31/2024

Type / Class
Equity / Common Stock
Shares outstanding
339M
Number of holders
122
Total 13F shares, excl. options
135M
Shares change
+503K
Total reported value, excl. options
$490M
Value change
+$4.26M
Put/Call ratio
0.07
Number of buys
63
Number of sells
-53
Price
$3.64

Significant Holders of Nuvation Bio Inc. - Common Stock (NUVB) as of Q1 2024

139 filings reported holding NUVB - Nuvation Bio Inc. - Common Stock as of Q1 2024.
Nuvation Bio Inc. - Common Stock (NUVB) has 122 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 135M shares of 339M outstanding shares and own 39.7% of the company stock.
Largest 10 shareholders include FMR LLC (27.7M shares), EcoR1 Capital, LLC (19.2M shares), Omega Fund Management, LLC (14.1M shares), BlackRock Inc. (12.5M shares), VANGUARD GROUP INC (7.53M shares), ABRAMS CAPITAL MANAGEMENT, L.P. (3.81M shares), TANG CAPITAL MANAGEMENT LLC (3.55M shares), GEODE CAPITAL MANAGEMENT, LLC (3.13M shares), STATE STREET CORP (3.04M shares), and Redmile Group, LLC (3.03M shares).
This table shows the top 122 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.